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Abstract.  Tubulin-tyrosine  ligase and a~-tubulin  form 
a  tight complex which  is conveniently monitored by 
glycerol gradient  centrifugation.  Using two distinct 
ligase monoclonal  antibodies,  several subunit-specific 
tubulin monoclonal  antibodies,  and chemical cross- 
linking,  a  ligase-binding  site was identified on 
13-tubulin.  This  site is retained when the carboxy- 
terminal  domains of both tubulin  subunits are removed 
by subtilisin treatment.  The ligase-tubulin  complex is 
also formed when ligase is added to al3-tubulin  carry- 
ing the monoclonal  antibody YL  1/2  which binds only 
to the carboxyl end of tyrosinated a-tubulin.  The 
13-tubulin-binding  site described here explains  the 
extreme  substrate  specificity of ligase,  which does not 
act on other cellular proteins  or carboxy-terminal  pep- 
tides derived from detyrosinated  a-tubulin.  Differential 
accessibility of this  site in tubulin  and in microtubules 
seems to explain  why ligase acts preferentially  on un- 
polymerized tubulin.  Ligase exposed to VS-protease is 
converted to a  nicked derivative.  This is devoid of 
enzymatic activity but still forms the complex with 
tubulin.  Gel electrophoresis documents both 30- and a 
14-kD domains,  each which is immunologically  and 
biochemically distinct  and seems to cover the entire 
molecule.  The two domains interact  tightly under 
physiological conditions.  The 30-kD domain carries 
the binding  sites for 13-tubulin  and ATP.  The  14-kD 
domain can possibly form an additional part of the 
catalytic site as it harbors  the epitope for the 
monoclonal antibody ID3  which inhibits  enzymatic 
activity but not the formation of the ligase-tubulin 
complex. 
THOUGH encoded by the mRNA (38), the carboxy-ter- 
minal tyrosine of a-tubulin shows turnover in cells 
and tissues (1, 4,  5,  22-24).  While the process of 
detyrosination by a putative carboxypeptidase is still poorly 
understood (2, 3, 17), certain aspects of the reverse reaction 
are well established in vitro (4, 5, 23-25). Tubulin-tyrosine 
ligase recharges the detyrosinated a-tubulin of al3-tubulin in 
an ATP-dependent reaction (5,  24).  The enzyme is highly 
specific for a-tubulin and does not act on other proteins pres- 
ent in the cell or in crude extracts (1, 4, 23). The reaction 
seems to occur on soluble al3-tubulin rather than on micro- 
tubules (1, 23, 36) in line with an isolatable complex formed 
between ligase and al3-tubulin (20, 24, 28). Ligase activity 
has been found in various vertebrates (22, 34), in several in- 
vertebrates (10, 16), and even in protozoa (32). In addition, 
all but two of the many a-tubulin genes described to date pre- 
dict the presence of a carboxy-terminal tyrosine residue (7, 
14, 39). In agreement, the monoclonal antibody YL 1/2 (15), 
which recognizes only the carboxyl end of tyrosinated a-tu- 
bulin (40, 42), has a broad cross-species reactivity extending 
from yeast to man and higher plants (15, 40--42).  Removal 
of the tyrosine abolishes antibody reactivity (40, 41). Various 
experiments including some with YL 1/2 show that the car- 
boxy-terminal domains of a- and 13-tubulin are not directly 
involved in the formation of the microtubular structure.  It 
rather  seems that these domains extend from the filament 
wall into the cytoplasm (26, 29, 42). Thus, the physiological 
role  of the  tyrosine  turnover  of a-tubulin  has  remained 
undefined. 
Previous work on the a-tubulin-specific ligase was greatly 
hampered by a cumbersome purification, yielding only small 
amounts of enzyme, which was found to be rather unstable 
(20).  We have recently developed a  rapid  immunoatfinity 
purification (28). This procedure and the use of glycerol as 
a stabilizing agent has made it possible to obtain milligram 
quantities  of ligase as a  stable enzyme preparation.  In the 
course of experiments aimed at the characterization of two 
distinct monoclonal antibodies to ligase, we found that the 
enzyme has two domains. Here we show that the stable com- 
plex between ligase and al3-tubulin involves a very strong 
binding  site,  which  surprisingly  locates  to  the  13-tubulin 
subunit. 
Materials and Methods 
Materials 
Chemicals were obtained as follows. L-[3,5-3H] Tyrosine (specific activity, 
57 Ci/mmol), [a-32p]ATP (3,000 Ci/mmol), and sodium [mI]iodide were 
from Amersham International, Amersham, UK; ATP and GTP were from 
Waldhof, Mannheim, Federal Republic of Germany; dimethylpimelimidate 
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Chemical Co.,  Rockford, IL;  1-ethyl-3(3-dimethylaminopropyl)carbodii- 
mide were from SERVA,  Heidelberg, FRG.  Subtilisin was from Sigma 
Chemical  Co.,  St.  Louis,  MO.  Staphylococcus VS-protease was  from 
Boehringer Marmheim GmbH,  Mannheim FRG.  Phosphocellulose (Pll) 
and Whatman 3MM filter paper were from Whatman Ltd., Maidstone, UK; 
CNBr-activated Sepharose 413 and DEAE-Sephacel were from Pharmacia, 
Freiburg, FRG. All other chemicals were from Sigma Chemical Co. 
Peroxidase-conjugated second antibodies were obtained from DAKO- 
PAT'I~,  Copenhagen, Denmark. The rat monoclonai ¢t-tubulin  antibodies 
(clones YL 1/2 and YOL 34) were generously provided by Dr. J. Kilmartin, 
Cambridge, England (15). The 13-tubulin-specific  mouse monoclonal anti- 
body (6) (clone DM1B) was from Amersham International. Nitrocellulose 
membrane filters (BA 83, 0.2 gm) were from Schleicher & Schuell, Dassel, 
FRG. 
Methods 
Pig brain microtubule protein was isolated by three cycles of temperature- 
dependent assembly/disassembly in 0.1 M  Pipes, pH 6.5,  1 mM MgSO4, 
1 mM EGTA,  1 mM GTP, and 1 mM 2-mercaptoethanol (30).  The first 
polymerization was done in the presence of 4  M  glycerol and 0.2 mM 
phenylmethylsulfonyl fluoride (PMSF). Homogeneous tubulin (PC-tubu- 
lin) was prepared from microtubule protein by phosphocellulose (PI1) chro- 
matography (31). Proteins were stored in aliquots at -700C. Tubulin-tyro- 
sine ligase from pig brain was purified by immunoaffinity chromatography 
using a mouse monocional antibody specific for ligase (clone LA/C4) as 
described (28). After elution from the affinity matrix with 3 M MgC12, the 
enzyme was dialyzed overnight at 4°C against stabilization buffer (25 mM 
K+MES [pH 6.8],  0.1 M KC1, 2 mM MgC12, 1 mM EGTA, 1 mM dithio- 
threitoi  [DT~,  20%  glycerol  [vol/vol])  and  then  stored in  aliquots at 
-70"C. Before use all protein samples were centrifuged for 20 rain at 4°C 
in a Beckman TL 100 centrifuge at 50,000  rpm. 
SDS PAGE and protein transfer from gels to nitrocellulose was performed 
as previously described (37). Usually peroxidase-labeled second antibodies 
were used for visualization. Protein concentrations were determined by the 
Lowry reagents using BSA as standard (18). Purified rabbit anti-ligase IgG's 
were directly iodinated using the IODO-GEN method (9). 
Antibody Production 
Monoclonal  Antibodies.  Four 6-wk-old female BALB/c mice were im- 
munized at  3-wk intervals with affinity-purified ligase (100-200  Ixg en- 
zyme/injection) using Freund's complete adjuvant for the first injection and 
incomplete adjuvant for the two subsequent injections. Sera were tested by 
immunodiffusion. The spleen cells from the mouse giving the strongest 
reaction were fused with cells from the myeloma line PAl (33) as described 
(28). Colony supernatants were screened by ELISA using 96-well microtiter 
plates.  All incubation steps were done at  37°C.  Approximately 0.5  Ixg 
purified ligase was provided per well. After 2 h, the wells were treated with 
PBS-BSA (4% wt/vol in PBS) for 2 h and then incubated with the colony 
supernatants. After a 2-h incubation, wells were washed five times with PBS 
before addition of pemxidase-eonjugated rabbit anti-mouse IgG's (diluted 
1:500 into PBS-BSA). After 1 h, wells were extensively washed with PBS, 
and then the substrate (H202;  o-phenylene diamine) was added. Positive 
supernatants were further tested in the ligase enzyme assay to identify anti- 
bodies which inhibited enzymatic activity. In addition, Western blotting was 
done.  Positive colonies were cloned twice by limiting dilution.  Ascites 
fluids were produced in BALB/c mice. After precipitation with 50% ammo- 
nium sulfate, dialysis against 10 mM sodium phosphate, pH 7.4, and loading 
on to DEAE-Sephacel, IgG's were eluted with 40 or 100 mM sodium phos- 
phate, pH 7.4. 
Polyclonal Antibodies.  Two rabbits were immunized with affinity-puri- 
fied ligase (200--400  gg enzyme/injection) using standard immunization 
procedures. Anti-ligase antibodies were isolated by affinity chromatogra- 
phy on ligase coupled to CNBr-activated Sepharose 4B. Specific antibodies 
were eluted with 0.2 M  sodium acetate, pH 2.5. 
Fab Fragments. IgG's purified from ascites fluids (clones LA/C4 and 
ID3) were digested for 8 h at 370C in 0.1 M sodium citrate, pH 4.0,  with 
10 gg pepsin per mg IgG (21). The reaction was stopped by addition of I M 
Tris-HCl, pH 8.8, to bring the pH to 7.0. F(ab)2 fragments were reduced 
with cysteine and then alkylated with iodoacetamide as described (21). Gel 
electrophoresis indicated full conversion of IgG to Fab. 
1. Abbreviation used in this paper: DMP, dimethylpimelimidate dihydro- 
chloride. 
Preparation of Crass-linked  Antibody Matrix.  ID3  antibodies were 
coupled to CNBr-activated Sepharose 4B (,~3 mg of purified IgG per ml 
of settled gel) and then cross-linked with 20 mM DMP essentially as de- 
scribed by Schneider et al.  (27). 
Ligase Assay.  Enzyme reactions were in 50 Itl containing 25 mM K + 
morpholinoethanesulfonic acid (MES) (pH 6.8),  150 mM KC1, 12.5 mM 
MgCIe, 2.5  mM ATP,  1 mM DTT,  100-200  Ixg microtubule protein or 
PC-tubulin, 0.1 mM L-[3H]tymsine, and 10 gl enzyme solution containing 
maximally 0.05 U as defined previously (23). For antibody tests, IgG's or 
Fab fragments were preincubated with ligase for 20 min at 4°C before add- 
ing the substrate. 
Photoaffinity Labeling. Direct photoaffinity labeling of intact and V8- 
treated ligase by ATP was performed essentially as described for myosin and 
actin (19). Between 10 and 50 gg protein in 50 gi ligase stabilization buffer, 
10 gCi of [¢t-32p]ATP, and 1 laM unlabeled ATP were irradiated at 4°C for 
20 min by UV light (wavelength 254 nm) at a distance of 4-6 cm. Samples 
were directly analyzed by SDS PAGE.  Gels were stained for protein with 
Coomassie R-250 dye, dried, and autoradiographed using Fuji RX-film. 
Protease  1keatment.  Ligase  (0.5  m~/ml  in  stabilization buffer)  was 
digested with Staphylococcus VS-protease (5 txg/rnl) for 1 to 8 h at 37°C. 
Incubation for 3  h  was sufficient to cleave >90%  of the ligase into two 
defined fragments (see Results). VS-protease was removed by affinity chro- 
matography on purified rabbit anti-VS-protease  IgG's (11) covalently coupled 
to Sepharose 4B (3 nag of purified IgG per ml of settled gel) and equilibrated 
with ligase stabilization buffer. The VS-protease-depleted  digest was stored 
in aiiquots at  -70°C. 
Glycerol Gradient Centrifugation.  Usually 300 ~tl samples were loaded 
onto linear glycerol gradients (10-20% [vol/vol])  in 25 mM K÷MES buffer 
(pH 6.8, supplemented with 1 mM MgCIz, 20 mM KC1, and 1 mM DTT) 
and centrifuged for 20 h at 4°C at 41,000 rpm in an SW41 rotor (Beckman 
Instruments, Inc., Palo Alto, CA). 0.4-ml fractions were collected and a 
10-~tl aliquot of each fraction was assayed for enzyme activity.  In parallel, 
a  l-gl aliquot of each fraction was spotted onto nitrocellulose sheets (13). 
Ligase was detected by  autoradiography  after exposure of the sheet to 
[125I]-labeled rabbit anti-ligase IgG's. 
Cross-linking  Studies.  (a)  Dimethylpimelimidate  dihydrochioride 
(DMP): Microtubule protein or PC-tubulin (1 mg/ml) and intact or VS-di- 
gested ligase (20-100  gg/ml) were dialyzed against the cross-linking buffer 
(0.1 M triethanolamine, pH 8.2, 20 mM KCI, 2 mM MgCI2, 2 mM DTT, 
10% glycerol [vol/vol])  for 2 h at 4°C. A 5 mg/ml stock solution of DMP 
was prepared in cross-linking buffer and the pH was readjusted to 8.2 with 
1 N NaOH.  150 ~tl of the stock solution was added per ml protein solution. 
Reaction was for 10 or 30 min at room temperature. The extent of cross- 
linking was estimated by SDS PAGE and Western blots. 
Addition of ATP (1  mM) did not affect the degree of cross-linking. 
Specific cross-linking was still obtained when the pH was lowered to 7.6 or 
6.8 -in order to minimize a possible denaturation of tubulin. Due to the re- 
duced reactivity of amino groups especially at pH 6.8 the extent of cross- 
linking was smaller than at pH 8.2. 
(b) 1-Ethyl-3-(3-dimethylaminopropyl)  carbodiimide (EDC): PC-tubulin 
(1 mg/ml) and ligase (0.1 mg/ml) in polymerization buffer (0.1 M Pipes, pH 
6.5,  1 mM MgSO4,  1 mM EGTA, 1 mM GTP,  1 mM 2-mereaptoethanol) 
were incubated for 1 h at 4°C. EDC was added from a stock solution (100 
mM in polymerization buffer) to a final concentration of 10 mM. After 10 
or 30 rain at room temperature, reaction products were analyzed as above. 
Subtilisin Digestion of Tubulin.  Subtilisin was dissolved at 1 mg/ml in 
water and stored in aliquots at -70°C. Digestion of PC-tubulin (5 mg/ml) 
was performed as described (26) in polymerization buffer at 37°C using 50 
gg subtilisin/ml. The reaction was stopped by adding 1% by volume of 1% 
(wt/vol) PMSF in DMSO. 
Polymerization Studies.  Microtubule protein was mixed with ligase at 
different concentrations in polymerization buffer and kept for 20 rain on ice. 
After temperature shift to 37°C, assembly was monitored by turbidity at 350 
nm. After 30 rain at 37°C, aliquots were negatively stained with 2% ura- 
nylacetate on carbon-coated grids and examined by electron microscopy. 
Results 
Two Distinct Monoclonal Antibodies: 
ID3 Inhibits Enzymatic Activity of  Ligase 
Monoclonal antibody LA/C4 allows a rapid purification of 
ligase as the native enzyme is released from the immuno- 
affinity matrix by 3 M MgCIE (28). As LA/C4 does not in- 
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Figure I. (A) Inhibition of ligase activity by monoclonal antibodies. 
1 14g of enzyme was preincubated with different concentrations of 
purified ID3 and LA/C4 IgG's or Fab fragments before addition of 
the tubulin substrate. LA/C4 IgG's (solid circles); ID3 IgG's (open 
circles); and ID3 Fab-fragments (open triangles). (B) Loss of ligase 
activity by V8-protease treatment. Ligase was incubated with V8- 
protease at 3"/°C; aliquots were removed each hour and incubated 
at 4°C for 20 min with rabbit anti-VS-protease IgG's coupled to 
Sepharose  to  remove the  protease.  After  sedimentation  of the 
Sepharose 10-141 aliquots of all samples were assayed for ligase ac- 
tivity.  Note  the  loss  of ligase  activity  after prolonged  protease 
treatment. 
hibit enzymatic activity (Fig.  1 A), a new set of monoclonal 
antibodies  was  raised.  Antibody  ID3  was  particularly  in- 
teresting.  This IgG1 recognizes  ligase specifically in West- 
ern Blots (Fig. 2) and effectively inhibits tyrosine incorpora- 
tion  into  tubulin.  This  property  is  fully  retained  in  Fab 
fragments prepared by standard procedures (Fig.  1 A). The 
properties of the two monoclonal antibodies and their ligase 
epitopes are summariied in Table I. In the course of estab- 
lishing these properties several interesting  aspects of the li- 
gase-tubulin  interaction  emerged. 
Two-domain Structure of  Ligase 
Purified ligase treated with V8-protease shows a characteris- 
tic time course of digestion when analyzed by SDS  PAGE. 
Under standard conditions the 40-kD protein is slowly con- 
verted into two  fragments,  which have apparent molecular 
masses of 30 and 14 kD, respectively (Fig. 2). Western blot- 
ting  showed  that  the  two  fragments  are  immunologically 
distinct.  ID3  recognized  only  the  14-kD  fragment,  while 
LA/C4  was specific for the 30-kD  fragment  (Fig.  2).  Pro- 
longed  treatment with protease  showed  further  cleavage of 
Figure 2. Analysis of ligase and its VS-protease digestion products 
by SDS  PAGE  (lanes  1  and  2)  and  corresponding  immunoblots 
(lanes 3-6);  localization of the ATP-binding site (lanes  7 and 8). 
Intact ligase (lane 1 ) was incubated with VS-protease for 3 h at 37°C 
and the digest was passed through a column of immobilized rabbit 
anti-VS-protease IgG's to  remove the  protease  (lane  2).  Corre- 
sponding gel slices of intact and fragmented ligase were transferred 
to nitrocellulose and incubated with LA/C4 (lanes 3 and 4) or ID3 
IgG's (lanes  5  and  6).  Bound  antibodies  were  visualized  with 
anti-mouse peroxidase-conjugated antibodies.  Of the two ligase- 
specific antibodies, LA/C4 labels the 30-kD fragment (lane 4) and 
ID3 the 14-kD fragment (lane 6). Note that some uncleaved ligase 
is still present in the digest (lanes 4 and 6;  see tex0.  For the au- 
toradiograms in lanes 7and 8, intact ligase (lane 7) and its V8 digest 
(lane 8) were incubated with [ct-32P]ATP, irradiated by UV light, 
and analyzed by SDS PAGE as described in Materials and Methods. 
Note the label on ligase and the 30-kD fragment. Molecular mass 
standards (66, 46,  29, and  14 kD) are indicated by bars at the left 
side (top to bottom). 
the fragments  (not shown).  Thus,  in most of the following 
experiments  preparations  were  used  that  still  contained 
~10%  uncleaved ligase (note for instance lanes 4  and  6  in 
Fig.  2).  Separate  experiments  showed  that  the  activity  of 
ligase  is  lost  parallel  to  the  incubation  with  VS-protease 
(Fig.  1 B). 
As in several attempts we were unable to separate the two 
fragments by gel filtration, we considered the possibility that 
the domains interact even after the protease has introduced 
at  least one polypeptide  break in  a  putative  hinge  region. 
Fragmented  as  well as intact  ligase  were tightly bound  by 
ID3 antibodies immobilized on Sepharose 4B. Neither intact 
enzyme nor its fragments were released when the  salt was 
raised to 1 M  Natl.  However, when the column was washed 
at 37°C with 4  M  urea solution,  the 30-kD fragment eluted 
while intact ligase and the  14-kD fragment remained bound 
Table I. Properties of  Ligase Monoclonal Antibodies 
LA/C4  ID3 
Antibody  type  IgG1  IgGl 
Elution  of antigen 
from antibody  3 M MgCI  2  urea >  4 M  (37°C) 
Inhibition  of ligase activity  -  + 
Inhibition  of tubulin- 
ligase complex formation  - 
Epitope  30 kD  14 kD 
Wehland and Weber Different Binding Sites of Tubulin-Tyrosine Ligase  1061 Table II. Properties of  the Two Ligase Domains 
Defined by V8-Protease 
30 kD  14 kD 
Monoelonal antibody  LA/C4  ID3 
ATP site  +  - 
I~-Tubulin-binding site  +  - 
(not shown). This result agrees with the Western blots show- 
ing that the epitope of ID3 is located on the 14-kD fragment 
(see above and Fig. 2, lane 6). In addition the experiments 
show that the two ligase domains still interact until 4 M urea 
is used. Additional support for this view is given below from 
experiments involving glycerol gradient centrifugation. 
The two domains of the ligase differ not only immunologi- 
cally but also functionally. Intact ligase and the digest were 
incubated with [a-3:P]-labeled  ATP and subjected to UV 
photolysis as  described  for other  nucleotide-triphosphate 
binding proteins (19). Subsequent gel electrophoresis and au- 
toradiography showed ATP  cross-linked to ligase and  its 
30-kD fragment, while the 14-kD domain remained free of 
label (Fig. 2, lanes 7and 8). The currently established prop- 
erties of the two domains are summarized in Table II. 
1193  Antibody Inhibits Enzymatic Activity 
but Does Not Interfere with the Formation of  the 
Ligase-Tubulin  Complex 
Ligase is known to form a one-to-one complex with al3-tu- 
bulin which can be monitored by glycerol gradient centrifu- 
gation and has an S value of 7.3 (28). Complex formation be- 
tween  ligase  and  tubulin  was  studied  with  both  ligase 
antibodies. To avoid possible problems of steric hindrance, 
Fab fragments rather than intact IgG molecules were used. 
Complex formation was followed by gradient centrifugation 
and enzyme activity assays of the resulting fractions. Alter- 
natively ligase was detected by dot assay using [t25I]-labeled 
rabbit anti-ligase antibodies. This assay is very reproducible 
and easy to perform. It is particularly useful for those ligase 
complexes which have lost enzymatic activity due to the 
binding of ID3 antibodies. 
Ligase and the ligase-tubulin complex sedimented with S 
values of 3.2 and 7.3, respectively (28).  Both species were 
clearly separated by glycerol gradient centrifugation (Fig. 3 
A; see also reference 28) in contrast to free tubulin with an 
S value of 6  and the ligase-tubulin complex (see inset in 
Fig. 3 A). In addition to the position of ligase and the ligase- 
tubulin complex, Fig. 3 A also shows the complexes formed 
between Fab fragments of LA/C4 and the free enzyme or the 
enzyme-tubulin complex.  These  antibody carrying com- 
plexes retain enzymatic activity (see also Fig.  1 A). Thus, 
ligase and its complexes are detected both by enzymatic ac- 
tivity and the dot assay. Only the latter procedure could be 
used to follow the complexes formed between Fab fragments 
of ID3 antibody and the ligase. Fig. 3 B shows that the li- 
gase-Fab complexes of ID3 sediment at the same position as 
seen for LA/C4 in Fig. 3 A. Preincubation with tubulin shifts 
the complex with ID3 to the position also recognized with 
LA/C4 (compare A and B in Fig. 3). Thus, the inhibiting an- 
tibody ID3  still allows the formation of the ligase-tubulin 
complex. The inhibition of enzymatic activity by ID3 (Fig.  1) 
Figure 3. Sedimentation  behavior of ligase and its complexes. 300- 
gl samples containing  various combinations  of intact ligase (25 ~tg) 
or VS-treated ligase (10 gg), PC-tubulin (500 I~g), and Fab frag- 
ments (300 ~tg) of LA/C4 and ID3 antibodies were preincubated 
for 20 min at room temperature before being loaded onto linear 
glycerol gradients (10-20% [vol/vol]). After centrifugation, 0.4-ml 
fractions were collected. (A) 10-1xl aliquots of all fractions were as- 
sayed  for ligase activity (TTL activity). The direction of sedimenta- 
tion is from left to right. Gradients shown are as follows: ligase 
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ysis of a complex between li- 
gase and tubulin obtained by 
chemical cross-linking. (a) Li- 
gase (lanes I and 2), PC-tubu- 
lin (lanes 3 and 4), and PC- 
tubniin  plus  ligase  (lanes  5 
and  6)  were  incubated  with 
(+) or without  (-) DMP as 
described  in  Materials  and 
Method, and analyzed  by SDS 
PAGE on a 6%  slab gel.  (b) 
An identical  gel as in a  was 
transferred  to  nitrocellulose 
and  incubated  with  [~I]rab- 
bit anti-ligase  antibodies  be- 
fore being  autoradiographed. 
Note the presence of a 100-kD 
ligase-positive  band obtained 
by cross-linking in the presence but not absence of  tubulin. This band, only poorly seen by dye staining, is clearly detected by ligase antibod- 
ies. (c-e) Gel slices corresponding to lanes 3-6in a were transferred to nitrocellulose sheets which were incubated with different monoclonal 
tubulin antibodies. Bound antibodies were visualized with peroxidase-conjugated second antibodies. (c) Anti-~-tubulin;  (d) anti-Q-tubniin 
(clone YL 1/2); (e) anti-¢t-tubulin (clone YOL 34). Note that the 100-kD ligase-tubulin cross-link is only detected by anti-~-tubulin  antibod- 
ies (c, lane 6) and not by anti-a-tubnlin antibodies (d and e). Molecular mass standards indicated at the left are as follows: 205, 116, 92, 
66, and 46 kD (top to bottom). 
is therefore not due to an antibody or Fab molecule hindering 
the interaction of ligase with the tubulin substrate. 
Glycerol gradient centrifugation was also used on VS-pro- 
tease-treated  ligase.  The  digested  enzyme  still  formed  a 
complex with ctl3-tubulin  which by SDS gel electrophoresis 
and Western blots revealed both ligase fragments (Fig. 3 C). 
Characterization of a Ligase-binding Site 
on fl-Tubulin 
To understand the a[~-tubulin-ligase complex in more detail 
(open circles); ligase and LA/C4 Fab fragments (solid circles); li- 
gase  and  PC-tubulin  (open  triangles);  ligase,  PC-tubulin,  and 
LA/C4 Fab fragments (solid triangles). Inset shows fractions 11 and 
13 obtained from the ligase plus tubulin glycerol gradient (open tri- 
angles) analyzed on a 15 % slab gel; bars indicate positions of  tubu- 
lin subunits not resolved and ligase, respectively. (B) l-B1 aliquots 
of each fraction of several glycerol gradients were spotted onto ni- 
trocellulose  sheets which were subsequently  saturated with BSA 
and incubated with [mI]rabbit anti-ligase  antibodies before auto- 
radiography. (a) Ligase; (b) ligase and LA/C4 Fab fragments; (c) 
ligase and ID3 Fab fragments; (d) ligase and PC-tubulin; (e) as for 
d but with LA/C4 Fab fragments as well; (f) as in d but with ID3 
Fab fragments as well.  Note the same shift of ligase (a) by both 
types of Fab fragments (b and c). Note also that the ligase-tubulin 
complex (c) is shifted by both Fab fragments (e and f) to the same 
extent. The positions of the various complexes seen in B are also 
found in A by enzyme tests as LA/C4 fragments do not inhibit the 
activity. (C) Fractions  11 (lane 1) and 13 (lane 2) obtained from a 
tubulin-ligase  glycerol gradient which was run with VS-treated li- 
gase instead of intact ligase, were analyzed by SDS PAGE on a 15 % 
slab gel (for comparison see inset in A). An identical gel slice was 
transferred to nitrocellulose and incubated with [~I]rabbit anti-li- 
gase before being autoradiographed  (lanes 3 and 4). Note that in 
addition to some uncleaved ligase present in the digest, VS-treated 
ligase still forms a complex with tubulin which contains both ligase 
fragments. Molecular  mass standards indicated at the left are 66, 
46, 29, and  14 kD (top to bottom). 
we performed various cross-linking studies with DMP in so- 
lution. Complexes were analyzed by gel electrophoresis fol- 
lowed by immunoblotting. Purified ligase is a monomer (20, 
28)  and  therefore no additional  cross-linked species were 
found when ligase alone was treated with the reagent. Cross- 
linking of al3-tubulin alone was relatively low (Fig. 4). Incu- 
bation of the cross-linker with a  mixture of both proteins 
yielded an additional band at ,MOO kD. While this band was 
barely  visible on  the  dye-stained gel  (Fig.  4  a,  see  also 
Fig.  6),  it was clearly recognized by polyclonal anti-ligase 
antibodies on the  corresponding blots  (Fig.  4  b,  lane  6). 
Only two bands were recognized by the polyclonal and the 
two monoclonal ligase antibodies: the normal ligase at 40 kD 
and a  tubulin-ligase complex at  100 kD.  Treatment of the 
same blots  with  several monoclonal antibodies  to  tubulin 
(Fig. 4, c-e) showed that the 100-kD species was recognized 
only by the 13-tubulin-specific antibody (clone DMIB) (Fig. 
4  c)  and  not by two  ¢t-tubulin-specific antibodies  (clones 
YOL34 and YL 1/2) (Fig. 4, d and e). Carbodiimide when 
used instead of DMP for cross-linking gave the same results. 
The resulting 100-kD complex of ligase was again only rec- 
ognized by the  [3-tubulin-specific antibody and not by the 
~t-tubulin-specific antibodies (not shown). 
When V8-treated ligase was used instead of intact enzyme, 
the cross-linked ligase-positive species was shifted from 100 
to "~85  kD (Fig.  5).  This suggested that the complex was 
formed between the 30-kD fragment of ligase and 13-tubu- 
lin. Immunoblotting confirmed this assumption. The cross- 
linked species was only detected with LA/C4 but not with 
ID3 antibodies (compare lanes 8  and 10 in Fig.  5). 
Mild digestion of tubulin with subtilisin is supposed to re- 
move '~30 carboxy-terminal residues from both ct- and 13-tu- 
bulin (26, 29). The actual cleavage sites on both tubulins have 
so far not been determined. The resulting derivative shows 
tubulin polymerization independent of microtubule-associ- 
ated proteins (26,  29). In our hands, a proteolytic treatment 
of 30 min at 37°C provided a useful tubulin derivative. Im- 
munoblots with YL 1/2 antibody, which is specific for tyrosi- 
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tubulin and intact ligase (lane 1) and PC-tubulin plus VS-treated li- 
gase (lane 2) were incubated with DMP as described in Materials 
and Methods and analyzed by SDS PAGE on a 7.5%  slab gel. VS- 
treated ligase ran close to the gel front and therefore barely detected 
by Coomassie staining (lane 2). Identical gel slices as in lanes I and 
2  were transferred to nitrocellulose sheets, which were incubated 
with the following  antibodies:  [~25I]rabbit  anti-ligase (lanes 3 and 
4);  13-tubulin antibody (lanes 5 and 6); LA/C4 antibody (lanes 7 
and  8);  ID3 antibody  (lanes  9  and  10). Bound  antibodies  were 
visualized  by  autoradiography  (lanes  3  and  4)  or  peroxidase- 
conjugated second antibodies (lanes 5-10).  Molecular mass stan- 
dards indicated at the left are as follows:  205,  116, 92, 66, and 46 
kD (top to bottom). Note the formation of an 85-kD cross-linked 
species in the V8-digest positive for ligase with polyclonal antibod- 
ies (lane 4), monoclonal anti-ligase LA/C4 (lane 8), but negative 
with  monoclonal  anti-ligase ID3  (lane 10). This  85-kD  species 
reacts with  I~-tubulin antibody (lane 6).  Due to the presence of 
some unfragmented ligase, an additional band at 100 kD can be seen 
which is also decorated by ID3. Other slots provide controls with 
intact ligase rather than fragmented ligase. 
Ligase Acts Preferentially on Tubulin 
Several studies indicate that soluble tubulin molecules rather 
than microtubules are the preferred substrate of the ligase (1, 
23).  Thus conditions which enhance microtubule formation 
seem to reduce tyrosine incorporation (36).  This view is in 
line with our experiments using taxol.  When microtubular 
protein was preincubated with  10 I~M taxol, tyrosine incor- 
poration decreased to 20%  of the control value in the stan- 
dard  assay.  When  ligase  was  mixed  with  taxol-stabilized 
microtubules,  subsequent  glycerol  gradient  centrifugation 
showed that essentially no enzyme sedimented with microtu- 
bules  (not  shown).  These  results  suggest  that  the  ligase- 
binding  site on tubulin is changed upon transition  from the 
tubulin monomer to the microtubular polymer. Thus we fol- 
lowed  microtubule  polymerization  in  the  presence  of  in- 
creasing  amounts  of  ligase  using  turbidity  measurements 
(Fig.  8).  Microtubule protein (0.5 mg/ml) was mixed in the 
cold with ligase (final concentration range, 0.05 to 1 mg/ml) 
and polymerization was started by temperature shift to 37°C. 
After 30 min at 37°C aliquots of all samples were also ana- 
lyzed by negative  staining  in the electron  microscope (not 
shown).  Only at higher ligase concentrations  was polymer- 
ization affected and at 0.3 mg/ml of ligase,  complete inhibi- 
tion was achieved (Fig.  8,  curve d),  no microtubules could 
be detected by electron microscopy. 
Discussion 
V8-protease was found to be a useful tool to define two dis- 
tinct domains of tubulin-tyrosine  ligase.  These separate in 
nated ~t-tubulin (40, 42), gave no reaction indicating that the 
carboxyl end of ¢t-tubulin  had been removed. 
Glycerol  gradient  centrifugation  showed  that  subtilisin- 
treated tubulin  retains binding  of ligase (not shown).  After 
cross-linking with DMP, two bands at 100 and 90 kD and the 
normal  40-kD  enzyme were  recognized  by  ligase-specific 
antibodies on corresponding blots (Fig. 6). The 100-kD band 
disappeared  in  preparations  which  had  been  more  exten- 
sively  treated  with  subtilisin  (compare  lanes  5  and  6  in 
Fig.  6).  Inununoblots  showed that the tubulin-ligase  cross- 
link  was  reactive both  with  ligase  (Fig.  6,  lanes  4-6)  and 
with  13-tubulin-specific  antibodies  (Fig.  6,  lanes  7-9). 
We also used glycerol gradient centrifugation to see wheth- 
er the monoclonal YL 1/2 antibody (15),  which specifically 
binds to the carboxyl end of tyrosinated  ¢t-tubulin (40, 42), 
might interfere with the formation of the ligase-tubulin com- 
plex. Fig. 7 shows that upon preincubation with YL 1/2 anti- 
body, the ligase-tubulin complex sedimented faster than the 
normal ligase-tubulin  complex.  Since in a  normal prepara- 
tion only some 10 % of the tubulin is tyrosinated, most of the 
ligase-tubulin  complex  remained  in  its  original  position. 
These results  show that the strong interaction between  ctl3- 
tubulin and ligase is not due to a binding site at the carboxyl 
end  of ct-tubulin,  where  the  ligase acts enzymatically,  but 
rather arises  from a  binding  site on the  13-tubulin. 
Figure 6. Analysis of ligase cross-linked to subtilisin-cleaved tubu- 
lin.  Tubulin was treated  with  subtilisin  for different times.  The 
resulting digests were incubated with ligase and cross-linking was 
performed with DMP as described in Materials and Methods. Li- 
gase cross-linked to normal tubulin (lane 1 ), 30-min tubulin digest 
(lane 2), and 20-min tubulin digest (lane 3) was analyzed by SDS 
PAGE on a 7.5%  slab gel.  Identical gel slices as lanes 1-3 were 
transferred  to  nitrocellulose  sheets,  which  were  incubated  with 
[uSI]mbbit anti-ligase antibodies (lanes 4-6) or anti-I]-tubulin an- 
tibody (lanes 7-9).  Bound antibodies were visualized by autoradi- 
ography (lanes 4-6)  or peroxidase-conjugated second antibodies 
(lanes 7-9).  Molecular mass standards indicated at ~e left are as 
follows:  205,  116, 92, 66, and 46 kD (top to bottom). "~.ote that all 
the cross-linked species displaying reactivity with ligaSe antibodies 
(lanes 4to 6) are also recognized in lanes 7-9by 13-tubulin antibody. 
The Journal of Cell Biology, Volume 104, 1987  1064 SDS gels as  14- and 30-kD fragments, although they bind 
tightly to each other under native conditions. This binding 
was retained in 1 M salt, and treatment with 4 M urea at 37°C 
was necessary to separate the fragments. Of the two distinct 
monoclonal antibodies to ligase characterized here, ID3 was 
specific for the 14-kD  fragment while LA/C4 only reacted 
with the 30-kD fragment. Thus it seems that the two frag- 
ments  span  different parts  of the ligase  molecule.  As  the 
molecular mass of ligase is ~43 kD (20, 28), the two frag- 
ments seem to cover the entire molecule. We cannot exclude, 
however, the possibility that a small peptide not detected by 
our current criteria was additionally released upon V8 treat- 
ment. The results indicate that the two domains of the ligase 
still tightly interact after the protease has introduced at least 
one polypeptide break into a connecting hinge region. For 
convenience the V8-treated enzyme is called nicked ligase. 
Although nicked ligase is devoid of enzymatic activity it 
retains the ability to form the one to one enzyme-substrate 
complex with tubulin, which can be monitored by glycerol 
gradient centrifugation. The stability of  this complex in solu- 
tion allowed us to study ligase-tubulin interaction by two 
chemical  cross-linking  reagents.  Complexes  revealed  by 
SDS PAGE were characterized by different monoclonal anti- 
bodies to tubulins and ligase. The results document an unex- 
pected ligase-binding site on 13-tubulin which involves the 
30-kD ligase domain. As ligase catalyzes the tyrosination of 
the a-subunit,  it has at least two contact points on its a~- 
tubulin substrate. One obviously involves the carboxyl end 
of a-tubulin  where the enzyme acts,  while the other lies 
within the 13-tubulin.  To assess the relative strength of the 
two sites in complex formation, we have made use of a tubu- 
lin derivative known to have lost the carboxy-terminal 3-kD 
domains on both subunits (26, 29). Subtilisin-treated afJ-tu- 
bulin  still  interacted both with normal and  nicked ligase. 
These results establish two important points on ligase-tubu- 
lin interaction. First, stable complex formation does not re- 
Figure  7. Sedimentation behavior of the tubulin-ligase complex in 
the presence of Y1  1/2 antibody. 300-1xl  samples containing ligase 
(25 I~g), PC-tubulin (500 ~tg), and YL 1/2 IgG's (1 nag) were prein- 
cubated for 20 min at room temperature before being loaded onto 
linear glycerol gradients (10-20% [vol/vol]). After centrifugation, 
0.4-ml fractions were collected and l%tl aliquots of all fractions of 
several glycerol gradients were spotted onto nitrocellulose sheets 
which were subsequently saturated with BSA. (a) Ligase; (b) ligase 
and PC-tubulin; (c and d) as in b but with YL 1/2 IgG's as well. 
a-c were incubated with [~2~I]rabbit anti-ligase  antibodies before 
autoradiography. YL 1/2 IgG's in d were visualized with peroxi- 
dase-conjugated second antibodies. The direction of sedimentation 
is from left to right. Note the shift of the tubulin ligase complex (b) 
by YL I/2 (c and d). 
0.05 
0025 
time I min) 
Figure  8.  Polymerization  of 
microtubule  protein  in  the 
presence  of ligase. Microtu- 
bule protein (0.5 mg/ml) and 
ligase (0.05-1 mg/ml) in poly- 
merization  buffer  were  pre- 
incubated for 20 min on ice 
before  polymerization  was 
initiated by shifting the tem- 
perature to 37°C. Ligase con- 
centrations: (a) no ligase, (b) 
0.1 mg/ml, (c) 0.2 mg/ml, (d) 
0.3 mg/ml. Note complete in- 
hibition of polymerization in 
curve d. 
quire the carboxyl end of a-tubulin, which is the site of en- 
zymatic action.  Second,  the  binding  site  on  13-tubulin is 
outside its carboxy-terminal 3-kD domain. The first conclu- 
sion was also obtained on normal al~-tubulin without resort- 
ing to the subtilisin derivative. Antibody YL 1/2 binds to the 
carboxyl end of a-tubulin provided the tyrosine is present 
(40, 42). Gradient centrifugation doeurnented a complex of 
al3-tubulin plus ligase carrying in addition the bulky IgG on 
the carboxyl end of the a-subunit.  Thus, we conclude that 
the in vitro interaction between al3-tubulin and ligase ob- 
served by various techniques does not require the carboxyl 
end of a-tubulin which is used during catalysis. 
The presence of a ligase-binding site on 13-tubulin opens 
an explanation for the high specificity of the enzyme. It does 
not act in vitro on peptides spanning the carboxyl-terminal 
residues of detyrosynated a-tubulin  (24;  our own unpub- 
lished results) or on denatured al3-tubulin (23); and in vitro 
and in vivo studies suggest that al3-tubulin is the only sub- 
strate in the cell (1, 4, 23).  This high degree of enzymatic 
specificity is expected if the binding to 13-tubulin is the pre- 
requisite  to  enzymatic action  at  the  carboxyl end  of the 
a-tubulin present in the same al3-tubulin molecule. Future 
experiments have to explore whether the different tubulin 
isotypes have an influence on the extent of tyrosination of the 
a-tubulins, since only some 50% of total brain tubulin has 
been reported to be tyrosinable in vitro (1). Therefore, espe- 
cially with respect to the heterogenous 13-tubulins, a subclass 
of tubulin isotypes might not act as substrate for ligase (for 
a  review on isotypes see references 7 and 39), 
While there is general agreement that monomeric al3-tu- 
bulin rather than the microtubule is the preferred ligase in 
vitro substrate (1, 23, 36), the reason for this distinction was 
unclear as the carboxy-terminal domain of a-tubulin seems 
to protrude from the filament wall (26, 29, 42). This problem 
seems now overcome by the identification of a site on 13-tu- 
bulin necessary for ligase binding. This site seems changed, 
weakened,  or  even  hidden  upon  transition  of tubulin  to 
microtubules. This would explain why preparations of mi- 
crotubular protein subjected to repeated cycles of polymer- 
ization and depolymerization lose most of the "contaminat- 
ing" ligase activity (24; our unpublished results). The enzyme 
stays  in  the  supernatant  as  tubulin-ligase  complex  once 
microtubules are harvested by centrifugation. Nevertheless, 
we found some ligase activity even in recycled microtubules. 
One possibility to account for this observation would be that 
tubulin molecules present at one or both ends of a microtu- 
Wehland and Weber Different Binding Sites of Tubulin-Tyrosine l-z'gase  1065 bule could still bind ligase possibly acting as a "capping" pro- 
tein. Our preliminary results support this view. At least un- 
der  in  vitro  conditions,  noticeable  inhibition  of  tubulin 
polymerization is found at high ligase concentration when 
microtubule  assembly  is  monitored by  turbidity  measure- 
ments or electron microscopy. 
Exploring the two domains of ligase delineated by VS-pro- 
tease (Table ID, we found that the ATP-binding  site of the en- 
zyme as well as its interaction site with 13-tubulin are located 
on the 30-kD fragment. While we cannot yet attach a direct 
biochemical function to the 14-kD fragment, we note that it 
binds the monoclonal antibody ID3. This assignment is im- 
portant as ID3 inhibits the enzymatic activity of ligase with- 
out interfering  with the formation of the tubulin-ligase com- 
plex. The same properties (i.e., ability of complex formation 
but no enzymatic activity) are typical for nicked ligase. Thus 
the  14-kD  fragment could carry  part  of the  catalytic  site. 
Even if the ATP-binding  pocket locates to the 30-kD  frag- 
ment as seen by photolysis experiments, the 14-kD  domain 
could still be  involved in recognizing the carboxyl end of 
a-tubulin. Alternatively the smaller domain may have an in- 
direct influence to transduce  the influence of a contact be- 
tween ligase and I~-tubulin on the catalytic center recogniz- 
ing the carboxyl end of ct-tubulin. 
Although  our experiments  have  unraveled  several  novel 
properties of tubulin-ligase interaction  and offer an explana- 
tion for the high specificity of the enzyme, they don't define 
the physiological importance of the metabolic turnover of the 
carboxy-terminal tyrosine of ~t-tubulin.  This is in part due 
to the poor characterization of the second process, which re- 
moves the tyrosine. This activity is usually called a carboxy- 
peptidase (2,  3,  17).  Its  specificity for vtl3-tubulin predicts 
that in addition to recognizing the carboxy-terminal end of 
tyrosinated  vt-tubulin,  it will have  like the ligase an addi- 
tional binding  site on the ctl3-tubulin molecule.  Several in 
vivo and in vitro experiments indicate that loss of the tyro- 
sine occurs on microtubules rather than on the pool of solu- 
ble tubulin  (17, 35).  Whether the in vivo detyrosination is 
solely  the  function of a  tubulin-specific  carboxypeptidase 
rather than  a reflection of a yet unidentified microtubular- 
mediated event is currently  not known. Recent reports based 
on immunocytochemical  studies open several  questions  as 
they  invoke separate  entities of microtubules harboring  or 
lacking the carboxy-terminal  tyrosine as  in some cultured 
cell lines (12).  In addition, during axonal maturation  of the 
cerebellar cortex, axonal and dendritic microtubules seem to 
differ in their degree of tyrosination  (8).  It is tempting  to 
speculate that  such heterogeneous  populations of microtu- 
boles might have  distinct functions. 
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